

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 7.44113433 |
| 2 | viral transcription (GO:0019083) | 7.07857239 |
| 3 | translational termination (GO:0006415) | 6.79096337 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 6.69445137 |
| 5 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.15379251 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 6.11011332 |
| 7 | protein targeting to ER (GO:0045047) | 6.03286072 |
| 8 | DNA deamination (GO:0045006) | 5.84198065 |
| 9 | translational elongation (GO:0006414) | 5.81867933 |
| 10 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.74199986 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 5.73170848 |
| 12 | maturation of SSU-rRNA (GO:0030490) | 5.65032632 |
| 13 | viral life cycle (GO:0019058) | 5.32176532 |
| 14 | cellular protein complex disassembly (GO:0043624) | 5.29285112 |
| 15 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.18436061 |
| 16 | translational initiation (GO:0006413) | 5.05932881 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 4.72338762 |
| 18 | proteasome assembly (GO:0043248) | 4.66645662 |
| 19 | protein complex disassembly (GO:0043241) | 4.56045193 |
| 20 | translation (GO:0006412) | 4.40170991 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.37640887 |
| 22 | macromolecular complex disassembly (GO:0032984) | 4.30807860 |
| 23 | ATP synthesis coupled proton transport (GO:0015986) | 4.21716693 |
| 24 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.21716693 |
| 25 | rRNA modification (GO:0000154) | 4.13164940 |
| 26 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.03448740 |
| 27 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.99553752 |
| 28 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.97619864 |
| 29 | termination of RNA polymerase III transcription (GO:0006386) | 3.97619864 |
| 30 | protein targeting to membrane (GO:0006612) | 3.90616987 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.89913319 |
| 32 | mRNA catabolic process (GO:0006402) | 3.84417746 |
| 33 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.81561687 |
| 34 | protein localization to mitochondrion (GO:0070585) | 3.76548468 |
| 35 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.74433210 |
| 36 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.73666964 |
| 37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.71303319 |
| 38 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.71303319 |
| 39 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.71303319 |
| 40 | inner mitochondrial membrane organization (GO:0007007) | 3.70455283 |
| 41 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.66874844 |
| 42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.66628835 |
| 43 | protein complex biogenesis (GO:0070271) | 3.61549380 |
| 44 | cellular component biogenesis (GO:0044085) | 3.60241711 |
| 45 | rRNA processing (GO:0006364) | 3.59587125 |
| 46 | ATP biosynthetic process (GO:0006754) | 3.59008123 |
| 47 | chaperone-mediated protein transport (GO:0072321) | 3.58876779 |
| 48 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.57563094 |
| 49 | 7-methylguanosine mRNA capping (GO:0006370) | 3.57500774 |
| 50 | establishment of integrated proviral latency (GO:0075713) | 3.56739725 |
| 51 | RNA catabolic process (GO:0006401) | 3.55524203 |
| 52 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.55043654 |
| 53 | 7-methylguanosine RNA capping (GO:0009452) | 3.53180787 |
| 54 | RNA capping (GO:0036260) | 3.53180787 |
| 55 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.50930173 |
| 56 | pseudouridine synthesis (GO:0001522) | 3.50322857 |
| 57 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.47634380 |
| 58 | telomere maintenance via recombination (GO:0000722) | 3.47232866 |
| 59 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.45876696 |
| 60 | rRNA metabolic process (GO:0016072) | 3.45126113 |
| 61 | DNA strand elongation (GO:0022616) | 3.42956604 |
| 62 | respiratory chain complex IV assembly (GO:0008535) | 3.41731313 |
| 63 | positive regulation of ligase activity (GO:0051351) | 3.41530228 |
| 64 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.40584724 |
| 65 | negative regulation of ligase activity (GO:0051352) | 3.40584724 |
| 66 | oxidative phosphorylation (GO:0006119) | 3.38425355 |
| 67 | formation of translation preinitiation complex (GO:0001731) | 3.37311749 |
| 68 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.37067412 |
| 69 | hydrogen ion transmembrane transport (GO:1902600) | 3.36924108 |
| 70 | GTP biosynthetic process (GO:0006183) | 3.36018832 |
| 71 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.35099175 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.33304166 |
| 73 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.33144309 |
| 74 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.30601900 |
| 75 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.29746482 |
| 76 | chromatin remodeling at centromere (GO:0031055) | 3.29298642 |
| 77 | spliceosomal snRNP assembly (GO:0000387) | 3.29106249 |
| 78 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.22825693 |
| 79 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.22770417 |
| 80 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.22770417 |
| 81 | cullin deneddylation (GO:0010388) | 3.22196444 |
| 82 | mitochondrial transport (GO:0006839) | 3.21838445 |
| 83 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.21497743 |
| 84 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.21330641 |
| 85 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.20800331 |
| 86 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.20800331 |
| 87 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.20800331 |
| 88 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.20339596 |
| 89 | DNA damage response, detection of DNA damage (GO:0042769) | 3.19147382 |
| 90 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.18390159 |
| 91 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.18390159 |
| 92 | spliceosomal complex assembly (GO:0000245) | 3.16329627 |
| 93 | respiratory electron transport chain (GO:0022904) | 3.15352941 |
| 94 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.13863022 |
| 95 | protein neddylation (GO:0045116) | 3.12947298 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.12679947 |
| 97 | rRNA methylation (GO:0031167) | 3.11987467 |
| 98 | regulation of ligase activity (GO:0051340) | 3.10813509 |
| 99 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.10217520 |
| 100 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.10217520 |
| 101 | mitotic recombination (GO:0006312) | 3.09353500 |
| 102 | electron transport chain (GO:0022900) | 3.08861193 |
| 103 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.06524918 |
| 104 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.06149734 |
| 105 | establishment of viral latency (GO:0019043) | 3.05632564 |
| 106 | UTP biosynthetic process (GO:0006228) | 3.04166615 |
| 107 | protein targeting to mitochondrion (GO:0006626) | 3.03331396 |
| 108 | telomere maintenance via telomere lengthening (GO:0010833) | 3.01249980 |
| 109 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.99741428 |
| 110 | histone mRNA metabolic process (GO:0008334) | 2.99529222 |
| 111 | termination of RNA polymerase I transcription (GO:0006363) | 2.99484786 |
| 112 | CENP-A containing nucleosome assembly (GO:0034080) | 2.98681624 |
| 113 | DNA replication initiation (GO:0006270) | 2.97124382 |
| 114 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.95809210 |
| 115 | transcription from RNA polymerase I promoter (GO:0006360) | 2.94718637 |
| 116 | peptidyl-histidine modification (GO:0018202) | 2.93886032 |
| 117 | establishment of protein localization to mitochondrion (GO:0072655) | 2.93576509 |
| 118 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.92933938 |
| 119 | regulation of mitochondrial translation (GO:0070129) | 2.92579682 |
| 120 | cytochrome complex assembly (GO:0017004) | 2.89535341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.38075976 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.37870957 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.33915754 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.31524783 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.19655101 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.02065071 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.72496832 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.63777936 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.50260961 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.40387069 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.13129002 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.06262856 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.03008791 |
| 14 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.96250614 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.92213885 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.88870721 |
| 17 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.83604582 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.78440592 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.76263474 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69854429 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.55592802 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.52565661 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.42031024 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.35604204 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.33208858 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.32205304 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.30276417 |
| 28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.18308059 |
| 29 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.15413419 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.11816452 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.11386518 |
| 32 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.11369292 |
| 33 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.05919883 |
| 34 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04937883 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04121029 |
| 36 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01668438 |
| 37 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.00781671 |
| 38 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99811787 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.98253226 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90002437 |
| 41 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.84516151 |
| 42 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.81278340 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77797804 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.73018428 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.69949651 |
| 46 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64928662 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.64520430 |
| 48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.57760221 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.56717124 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54296831 |
| 51 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51610578 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51326634 |
| 53 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49738275 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48003818 |
| 55 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.47845353 |
| 56 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.47244723 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.40988013 |
| 58 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40408716 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.38904991 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35806878 |
| 61 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35287327 |
| 62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.34788498 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29171817 |
| 64 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.28746115 |
| 65 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.26318469 |
| 66 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24284027 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18523060 |
| 68 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14136236 |
| 69 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13976826 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13556249 |
| 71 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12857405 |
| 72 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12742830 |
| 73 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.12715393 |
| 74 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11249172 |
| 75 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11097134 |
| 76 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08793154 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.07283640 |
| 78 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.04604482 |
| 79 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.04088846 |
| 80 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.03765496 |
| 81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03149025 |
| 82 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.02604610 |
| 83 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02422013 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.02164542 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01992012 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00397280 |
| 87 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98745944 |
| 88 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98619481 |
| 89 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98419267 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.97430939 |
| 91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97342553 |
| 92 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95243816 |
| 93 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94157792 |
| 94 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93010682 |
| 95 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92121334 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87773302 |
| 97 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87512425 |
| 98 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86484641 |
| 99 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86173634 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.86064702 |
| 101 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85213640 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.84501856 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83925846 |
| 104 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.82671158 |
| 105 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.81486536 |
| 106 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80736131 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79723601 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78527140 |
| 109 | * VDR_21846776_ChIP-Seq_THP-1_Human | 0.78081409 |
| 110 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.78018136 |
| 111 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75967533 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75197593 |
| 113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.74646186 |
| 114 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.74150362 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.73618264 |
| 116 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.72090010 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.71352552 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.70703753 |
| 119 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.70290296 |
| 120 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.70037098 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.65205896 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.87796999 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 3.29280599 |
| 4 | MP0008057_abnormal_DNA_replication | 3.13148264 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.06957595 |
| 6 | MP0010030_abnormal_orbit_morphology | 3.01759488 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.80148948 |
| 8 | MP0008058_abnormal_DNA_repair | 2.74743808 |
| 9 | MP0003077_abnormal_cell_cycle | 2.63240275 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.54832011 |
| 11 | MP0008007_abnormal_cellular_replicative | 2.33773838 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.30668473 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.28853201 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.22175318 |
| 15 | MP0001529_abnormal_vocalization | 2.19961478 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.13757409 |
| 17 | MP0003786_premature_aging | 2.10312543 |
| 18 | MP0008932_abnormal_embryonic_tissue | 2.00655287 |
| 19 | MP0005174_abnormal_tail_pigmentation | 2.00580901 |
| 20 | MP0005671_abnormal_response_to | 1.98337586 |
| 21 | MP0001905_abnormal_dopamine_level | 1.90644037 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.90207841 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 1.87785942 |
| 24 | MP0009785_altered_susceptibility_to | 1.87240087 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.86363836 |
| 26 | MP0002132_abnormal_respiratory_system | 1.85249122 |
| 27 | MP0001293_anophthalmia | 1.77443250 |
| 28 | MP0003724_increased_susceptibility_to | 1.77247978 |
| 29 | MP0002938_white_spotting | 1.76839233 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.69331885 |
| 31 | MP0002638_abnormal_pupillary_reflex | 1.68238769 |
| 32 | MP0000490_abnormal_crypts_of | 1.60729908 |
| 33 | MP0003186_abnormal_redox_activity | 1.58118496 |
| 34 | MP0003941_abnormal_skin_development | 1.57046174 |
| 35 | MP0003718_maternal_effect | 1.52687928 |
| 36 | MP0002398_abnormal_bone_marrow | 1.50948207 |
| 37 | MP0005409_darkened_coat_color | 1.50349939 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.49685754 |
| 39 | MP0001800_abnormal_humoral_immune | 1.49423791 |
| 40 | MP0002163_abnormal_gland_morphology | 1.48949150 |
| 41 | MP0002234_abnormal_pharynx_morphology | 1.47735864 |
| 42 | MP0005025_abnormal_response_to | 1.47714456 |
| 43 | MP0000685_abnormal_immune_system | 1.45542051 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.39213184 |
| 45 | MP0000372_irregular_coat_pigmentation | 1.38340236 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.38221742 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.37024954 |
| 48 | MP0002723_abnormal_immune_serum | 1.36661593 |
| 49 | MP0001188_hyperpigmentation | 1.35646498 |
| 50 | MP0002722_abnormal_immune_system | 1.35591450 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.35444761 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.35008292 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.35008292 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.34583052 |
| 55 | MP0001819_abnormal_immune_cell | 1.32900759 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.30750634 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.30606911 |
| 58 | MP0002653_abnormal_ependyma_morphology | 1.29024845 |
| 59 | MP0000716_abnormal_immune_system | 1.28419873 |
| 60 | MP0003315_abnormal_perineum_morphology | 1.27358676 |
| 61 | MP0008995_early_reproductive_senescence | 1.26445450 |
| 62 | MP0001853_heart_inflammation | 1.25183501 |
| 63 | MP0000537_abnormal_urethra_morphology | 1.24647341 |
| 64 | MP0002429_abnormal_blood_cell | 1.23707372 |
| 65 | MP0004381_abnormal_hair_follicle | 1.22329494 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 1.21929438 |
| 67 | MP0003136_yellow_coat_color | 1.21420650 |
| 68 | MP0002736_abnormal_nociception_after | 1.19743135 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.17912792 |
| 70 | MP0002405_respiratory_system_inflammati | 1.11326415 |
| 71 | MP0003123_paternal_imprinting | 1.07661066 |
| 72 | MP0000313_abnormal_cell_death | 1.07159751 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.06409985 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 1.04982516 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.04597364 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.04529952 |
| 77 | MP0003436_decreased_susceptibility_to | 1.03988414 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.03255876 |
| 79 | MP0004147_increased_porphyrin_level | 1.03157105 |
| 80 | MP0001881_abnormal_mammary_gland | 1.03046169 |
| 81 | MP0001346_abnormal_lacrimal_gland | 1.02133099 |
| 82 | MP0001790_abnormal_immune_system | 1.01647369 |
| 83 | MP0005387_immune_system_phenotype | 1.01647369 |
| 84 | MP0008877_abnormal_DNA_methylation | 1.00455760 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.99898851 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.99898007 |
| 87 | MP0005408_hypopigmentation | 0.98973677 |
| 88 | MP0004142_abnormal_muscle_tone | 0.97970682 |
| 89 | MP0000653_abnormal_sex_gland | 0.97814838 |
| 90 | MP0001697_abnormal_embryo_size | 0.97761096 |
| 91 | MP0001730_embryonic_growth_arrest | 0.97652950 |
| 92 | MP0003866_abnormal_defecation | 0.97162317 |
| 93 | MP0001929_abnormal_gametogenesis | 0.94492238 |
| 94 | MP0009697_abnormal_copulation | 0.92961976 |
| 95 | MP0006054_spinal_hemorrhage | 0.92935253 |
| 96 | MP0002419_abnormal_innate_immunity | 0.92885455 |
| 97 | MP0000566_synostosis | 0.92194225 |
| 98 | MP0002837_dystrophic_cardiac_calcinosis | 0.91045639 |
| 99 | MP0001919_abnormal_reproductive_system | 0.90515768 |
| 100 | MP0002751_abnormal_autonomic_nervous | 0.90432099 |
| 101 | MP0002102_abnormal_ear_morphology | 0.89656597 |
| 102 | MP0005499_abnormal_olfactory_system | 0.89537257 |
| 103 | MP0005394_taste/olfaction_phenotype | 0.89537257 |
| 104 | MP0005389_reproductive_system_phenotype | 0.88433179 |
| 105 | MP0000350_abnormal_cell_proliferation | 0.87856652 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.87610867 |
| 107 | MP0003938_abnormal_ear_development | 0.86946707 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86899338 |
| 109 | MP0002697_abnormal_eye_size | 0.86823834 |
| 110 | MP0001286_abnormal_eye_development | 0.86730227 |
| 111 | MP0008875_abnormal_xenobiotic_pharmacok | 0.86007404 |
| 112 | MP0005501_abnormal_skin_physiology | 0.85529745 |
| 113 | MP0002210_abnormal_sex_determination | 0.83756731 |
| 114 | MP0005645_abnormal_hypothalamus_physiol | 0.82960786 |
| 115 | MP0001764_abnormal_homeostasis | 0.81365282 |
| 116 | MP0002085_abnormal_embryonic_tissue | 0.80840261 |
| 117 | MP0002090_abnormal_vision | 0.80067448 |
| 118 | MP0000858_altered_metastatic_potential | 0.79350786 |
| 119 | MP0003937_abnormal_limbs/digits/tail_de | 0.78877289 |
| 120 | MP0005332_abnormal_amino_acid | 0.77829901 |
| 121 | MP0004133_heterotaxia | 0.76290001 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.76276950 |
| 123 | MP0005253_abnormal_eye_physiology | 0.75465843 |
| 124 | MP0006072_abnormal_retinal_apoptosis | 0.75275954 |
| 125 | MP0002080_prenatal_lethality | 0.75181649 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.74928665 |
| 127 | MP0008789_abnormal_olfactory_epithelium | 0.74077351 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.72244557 |
| 129 | MP0008872_abnormal_physiological_respon | 0.71719348 |
| 130 | MP0000358_abnormal_cell_content/ | 0.71478928 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.71460618 |
| 132 | MP0002160_abnormal_reproductive_system | 0.71226455 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.71105566 |
| 134 | MP0002111_abnormal_tail_morphology | 0.70631652 |
| 135 | MP0001119_abnormal_female_reproductive | 0.70598589 |
| 136 | MP0003656_abnormal_erythrocyte_physiolo | 0.70329324 |
| 137 | MP0000762_abnormal_tongue_morphology | 0.69178129 |
| 138 | MP0000049_abnormal_middle_ear | 0.69086416 |
| 139 | MP0003011_delayed_dark_adaptation | 0.68965629 |
| 140 | MP0005377_hearing/vestibular/ear_phenot | 0.66341310 |
| 141 | MP0003878_abnormal_ear_physiology | 0.66341310 |
| 142 | MP0005551_abnormal_eye_electrophysiolog | 0.65977776 |
| 143 | MP0001145_abnormal_male_reproductive | 0.65637263 |
| 144 | MP0002006_tumorigenesis | 0.65632729 |
| 145 | MP0001727_abnormal_embryo_implantation | 0.65483629 |
| 146 | MP0002796_impaired_skin_barrier | 0.64778367 |
| 147 | MP0005410_abnormal_fertilization | 0.63863925 |
| 148 | MP0002233_abnormal_nose_morphology | 0.63611499 |
| 149 | MP0003283_abnormal_digestive_organ | 0.63591412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.67425225 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.25619920 |
| 3 | Reticulocytopenia (HP:0001896) | 5.52597000 |
| 4 | Macrocytic anemia (HP:0001972) | 4.41728914 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.33598039 |
| 6 | Pallor (HP:0000980) | 4.24085700 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.18256355 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 4.14863884 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.11594461 |
| 10 | 3-Methylglutaconic aciduria (HP:0003535) | 4.11281223 |
| 11 | Aplastic anemia (HP:0001915) | 4.03019839 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.82002341 |
| 13 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.82002341 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.73056892 |
| 15 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.72101941 |
| 16 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.65070410 |
| 17 | Increased CSF lactate (HP:0002490) | 3.64508573 |
| 18 | Renal Fanconi syndrome (HP:0001994) | 3.59917875 |
| 19 | Exertional dyspnea (HP:0002875) | 3.58491725 |
| 20 | Lipid accumulation in hepatocytes (HP:0006561) | 3.55498007 |
| 21 | Hepatic necrosis (HP:0002605) | 3.46722554 |
| 22 | Progressive macrocephaly (HP:0004481) | 3.34371901 |
| 23 | Acute encephalopathy (HP:0006846) | 3.16600665 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 3.05992070 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 3.05457881 |
| 26 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.98748622 |
| 27 | Increased serum lactate (HP:0002151) | 2.94742607 |
| 28 | Birth length less than 3rd percentile (HP:0003561) | 2.91451687 |
| 29 | Respiratory difficulties (HP:0002880) | 2.75876982 |
| 30 | IgM deficiency (HP:0002850) | 2.75641751 |
| 31 | Testicular atrophy (HP:0000029) | 2.75328123 |
| 32 | Oral leukoplakia (HP:0002745) | 2.69434522 |
| 33 | Exercise intolerance (HP:0003546) | 2.66706190 |
| 34 | Lethargy (HP:0001254) | 2.56915036 |
| 35 | Thrombocytosis (HP:0001894) | 2.54929201 |
| 36 | Lactic acidosis (HP:0003128) | 2.49893615 |
| 37 | 11 pairs of ribs (HP:0000878) | 2.47522112 |
| 38 | Microvesicular hepatic steatosis (HP:0001414) | 2.46767195 |
| 39 | Hypothermia (HP:0002045) | 2.42455825 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.41804553 |
| 41 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.39985701 |
| 42 | Type 2 muscle fiber atrophy (HP:0003554) | 2.37102597 |
| 43 | Methylmalonic aciduria (HP:0012120) | 2.36758437 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.36481946 |
| 45 | Muscle fiber atrophy (HP:0100295) | 2.34647841 |
| 46 | Abnormality of the anterior horn cell (HP:0006802) | 2.34044196 |
| 47 | Degeneration of anterior horn cells (HP:0002398) | 2.34044196 |
| 48 | Breast hypoplasia (HP:0003187) | 2.33369432 |
| 49 | Generalized aminoaciduria (HP:0002909) | 2.31789516 |
| 50 | Respiratory failure (HP:0002878) | 2.28991868 |
| 51 | Abnormality of renal resorption (HP:0011038) | 2.26098720 |
| 52 | Abnormality of urine glucose concentration (HP:0011016) | 2.25900798 |
| 53 | Glycosuria (HP:0003076) | 2.25900798 |
| 54 | Pancytopenia (HP:0001876) | 2.21676912 |
| 55 | Petechiae (HP:0000967) | 2.19434432 |
| 56 | Abnormality of methionine metabolism (HP:0010901) | 2.14363159 |
| 57 | Hyperphosphaturia (HP:0003109) | 2.12830658 |
| 58 | Rough bone trabeculation (HP:0100670) | 2.10203809 |
| 59 | Cerebral hypomyelination (HP:0006808) | 2.09330320 |
| 60 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.08106916 |
| 61 | Microretrognathia (HP:0000308) | 2.08019650 |
| 62 | Optic disc pallor (HP:0000543) | 2.06273123 |
| 63 | CNS demyelination (HP:0007305) | 2.04613625 |
| 64 | Premature graying of hair (HP:0002216) | 2.04474433 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.03600745 |
| 66 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.03487806 |
| 67 | Absent thumb (HP:0009777) | 2.03212785 |
| 68 | Abnormal protein glycosylation (HP:0012346) | 2.03025288 |
| 69 | Abnormal glycosylation (HP:0012345) | 2.03025288 |
| 70 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.03025288 |
| 71 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.03025288 |
| 72 | Septo-optic dysplasia (HP:0100842) | 2.01315850 |
| 73 | X-linked dominant inheritance (HP:0001423) | 1.98280546 |
| 74 | Pancreatic fibrosis (HP:0100732) | 1.95905766 |
| 75 | Depressed nasal ridge (HP:0000457) | 1.92907644 |
| 76 | Emotional lability (HP:0000712) | 1.92065250 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 1.91917989 |
| 78 | Abnormality of the preputium (HP:0100587) | 1.91347097 |
| 79 | Parakeratosis (HP:0001036) | 1.90875157 |
| 80 | Cerebral edema (HP:0002181) | 1.88601264 |
| 81 | Leukodystrophy (HP:0002415) | 1.88043948 |
| 82 | True hermaphroditism (HP:0010459) | 1.86866353 |
| 83 | Abnormality of alanine metabolism (HP:0010916) | 1.86860346 |
| 84 | Hyperalaninemia (HP:0003348) | 1.86860346 |
| 85 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.86860346 |
| 86 | Myelodysplasia (HP:0002863) | 1.85810927 |
| 87 | Chromsome breakage (HP:0040012) | 1.85457959 |
| 88 | Megaloblastic anemia (HP:0001889) | 1.85373588 |
| 89 | IgG deficiency (HP:0004315) | 1.84764646 |
| 90 | Poor head control (HP:0002421) | 1.84526573 |
| 91 | Abnormality of placental membranes (HP:0011409) | 1.83465439 |
| 92 | Amniotic constriction ring (HP:0009775) | 1.83465439 |
| 93 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.79520980 |
| 94 | Abnormality of the axillary hair (HP:0100134) | 1.79060401 |
| 95 | Abnormality of secondary sexual hair (HP:0009888) | 1.79060401 |
| 96 | Severe visual impairment (HP:0001141) | 1.78682664 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 1.78011950 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78011950 |
| 99 | Triphalangeal thumb (HP:0001199) | 1.77613105 |
| 100 | Pancreatic cysts (HP:0001737) | 1.77009013 |
| 101 | Hypoplasia of the pons (HP:0012110) | 1.76716929 |
| 102 | Recurrent abscess formation (HP:0002722) | 1.75668627 |
| 103 | Neutropenia (HP:0001875) | 1.74879024 |
| 104 | Abnormal lung lobation (HP:0002101) | 1.74374532 |
| 105 | Concave nail (HP:0001598) | 1.74194956 |
| 106 | Hyperglycinemia (HP:0002154) | 1.74104941 |
| 107 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74058697 |
| 108 | Carpal bone hypoplasia (HP:0001498) | 1.73954502 |
| 109 | Bone marrow hypocellularity (HP:0005528) | 1.73013276 |
| 110 | Absent septum pellucidum (HP:0001331) | 1.72395830 |
| 111 | Abnormality of serum amino acid levels (HP:0003112) | 1.72290812 |
| 112 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71741927 |
| 113 | Meckel diverticulum (HP:0002245) | 1.70172034 |
| 114 | Abnormal trabecular bone morphology (HP:0100671) | 1.70014386 |
| 115 | Abnormality of the pons (HP:0007361) | 1.69854232 |
| 116 | Cleft eyelid (HP:0000625) | 1.67647725 |
| 117 | Blindness (HP:0000618) | 1.67597768 |
| 118 | Chronic otitis media (HP:0000389) | 1.67427117 |
| 119 | Progressive muscle weakness (HP:0003323) | 1.66919066 |
| 120 | Multiple enchondromatosis (HP:0005701) | 1.66133471 |
| 121 | Sparse eyelashes (HP:0000653) | 1.65738346 |
| 122 | Lymphoma (HP:0002665) | 1.65713149 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 1.65490306 |
| 124 | Pulmonary fibrosis (HP:0002206) | 1.64150623 |
| 125 | Sclerocornea (HP:0000647) | 1.64113389 |
| 126 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.63964636 |
| 127 | Renal tubular dysfunction (HP:0000124) | 1.63510819 |
| 128 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.63023404 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.62638207 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.62638207 |
| 131 | Patellar aplasia (HP:0006443) | 1.62503515 |
| 132 | Asplenia (HP:0001746) | 1.62462535 |
| 133 | Congenital, generalized hypertrichosis (HP:0004540) | 1.62027188 |
| 134 | Colon cancer (HP:0003003) | 1.62008098 |
| 135 | Cellular immunodeficiency (HP:0005374) | 1.60232340 |
| 136 | Patchy hypopigmentation of hair (HP:0011365) | 1.59585596 |
| 137 | Abnormality of midbrain morphology (HP:0002418) | 1.58602578 |
| 138 | Molar tooth sign on MRI (HP:0002419) | 1.58602578 |
| 139 | Abnormality of the labia minora (HP:0012880) | 1.58069224 |
| 140 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.56994062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 6.66736290 |
| 2 | STK16 | 4.61910972 |
| 3 | NME2 | 3.95539917 |
| 4 | BUB1 | 3.92673032 |
| 5 | VRK1 | 3.04807012 |
| 6 | WEE1 | 2.84322132 |
| 7 | SRPK1 | 2.22742159 |
| 8 | MAP3K12 | 2.20240147 |
| 9 | PIM2 | 2.14456242 |
| 10 | TAF1 | 2.04778478 |
| 11 | TLK1 | 2.02198570 |
| 12 | EIF2AK1 | 1.91575187 |
| 13 | EIF2AK3 | 1.88406876 |
| 14 | MAP4K1 | 1.82035139 |
| 15 | PLK4 | 1.77419376 |
| 16 | MUSK | 1.73281938 |
| 17 | NME1 | 1.73266911 |
| 18 | BRSK2 | 1.70759029 |
| 19 | NEK1 | 1.70155656 |
| 20 | ACVR1B | 1.67023870 |
| 21 | IRAK4 | 1.66428449 |
| 22 | NUAK1 | 1.61747228 |
| 23 | CDK8 | 1.59858029 |
| 24 | TESK1 | 1.55358331 |
| 25 | MAPKAPK5 | 1.55201255 |
| 26 | MKNK1 | 1.55097226 |
| 27 | DYRK3 | 1.44230388 |
| 28 | TEC | 1.43232306 |
| 29 | CDC7 | 1.39367146 |
| 30 | TXK | 1.34833443 |
| 31 | TGFBR1 | 1.33887946 |
| 32 | TSSK6 | 1.29967324 |
| 33 | RPS6KB2 | 1.27763031 |
| 34 | BTK | 1.26553217 |
| 35 | ADRBK2 | 1.24552268 |
| 36 | CDK7 | 1.23795836 |
| 37 | TNIK | 1.23235981 |
| 38 | KIT | 1.22730360 |
| 39 | LIMK1 | 1.14672902 |
| 40 | CDK19 | 1.13785356 |
| 41 | MST4 | 1.13560416 |
| 42 | MKNK2 | 1.13341743 |
| 43 | BMPR1B | 1.11423006 |
| 44 | KDR | 1.10277508 |
| 45 | PBK | 1.09223889 |
| 46 | CCNB1 | 1.07153449 |
| 47 | RPS6KA5 | 1.04615615 |
| 48 | BLK | 0.98342451 |
| 49 | PLK1 | 0.97790293 |
| 50 | AURKB | 0.96976027 |
| 51 | TESK2 | 0.96760421 |
| 52 | GRK7 | 0.94770170 |
| 53 | PASK | 0.94380685 |
| 54 | RPS6KA4 | 0.93737646 |
| 55 | DAPK1 | 0.91895969 |
| 56 | MAP4K2 | 0.90057723 |
| 57 | PDK2 | 0.89454311 |
| 58 | DYRK2 | 0.88102608 |
| 59 | EIF2AK2 | 0.87628262 |
| 60 | PRKCI | 0.86758455 |
| 61 | BRSK1 | 0.85943269 |
| 62 | ATR | 0.83953137 |
| 63 | AURKA | 0.83952847 |
| 64 | SYK | 0.83273395 |
| 65 | IRAK3 | 0.83051559 |
| 66 | IKBKB | 0.83048247 |
| 67 | SMG1 | 0.82905370 |
| 68 | ZAK | 0.81699128 |
| 69 | MYLK | 0.81139939 |
| 70 | PAK4 | 0.79505635 |
| 71 | ZAP70 | 0.77042428 |
| 72 | EPHA2 | 0.76673949 |
| 73 | MAP3K11 | 0.76046452 |
| 74 | DAPK3 | 0.75564191 |
| 75 | CSNK2A1 | 0.72637132 |
| 76 | BRAF | 0.72582894 |
| 77 | LYN | 0.71743825 |
| 78 | LRRK2 | 0.71435768 |
| 79 | NEK2 | 0.71192995 |
| 80 | NLK | 0.69886295 |
| 81 | CSNK1G3 | 0.69439028 |
| 82 | PIM1 | 0.68432466 |
| 83 | SCYL2 | 0.67989797 |
| 84 | CSNK2A2 | 0.67818457 |
| 85 | BCKDK | 0.67038221 |
| 86 | IKBKE | 0.64965624 |
| 87 | PLK3 | 0.63701091 |
| 88 | YES1 | 0.63063422 |
| 89 | ILK | 0.62302843 |
| 90 | ABL2 | 0.62240689 |
| 91 | CSF1R | 0.62038432 |
| 92 | ARAF | 0.61738681 |
| 93 | FLT3 | 0.60640200 |
| 94 | MAPK15 | 0.58619251 |
| 95 | MAP2K7 | 0.57561815 |
| 96 | GRK1 | 0.56864533 |
| 97 | CHEK2 | 0.56640074 |
| 98 | WNK3 | 0.54338407 |
| 99 | TYK2 | 0.53322977 |
| 100 | LCK | 0.51592729 |
| 101 | TRIM28 | 0.51285394 |
| 102 | CSNK1G2 | 0.50967422 |
| 103 | CLK1 | 0.49591358 |
| 104 | MATK | 0.47667441 |
| 105 | JAK3 | 0.46328983 |
| 106 | CSNK1G1 | 0.45034424 |
| 107 | TTK | 0.44973475 |
| 108 | CSNK1A1L | 0.44473923 |
| 109 | MAPK4 | 0.44412547 |
| 110 | TAOK3 | 0.43733650 |
| 111 | MAPKAPK3 | 0.43693115 |
| 112 | PAK1 | 0.43268433 |
| 113 | TBK1 | 0.40356595 |
| 114 | CHEK1 | 0.39876503 |
| 115 | RPS6KA6 | 0.39508864 |
| 116 | SIK3 | 0.38865627 |
| 117 | MAPK13 | 0.38174181 |
| 118 | GRK6 | 0.35798205 |
| 119 | WNK4 | 0.35417083 |
| 120 | IRAK1 | 0.34251569 |
| 121 | RPS6KC1 | 0.33435129 |
| 122 | RPS6KL1 | 0.33435129 |
| 123 | STK4 | 0.32916641 |
| 124 | EPHB2 | 0.32514569 |
| 125 | ATM | 0.29598268 |
| 126 | CSNK1E | 0.28598193 |
| 127 | GRK5 | 0.27701584 |
| 128 | CSNK1A1 | 0.26612289 |
| 129 | STK24 | 0.25650363 |
| 130 | AKT2 | 0.25194340 |
| 131 | TAOK2 | 0.23188635 |
| 132 | INSRR | 0.22677384 |
| 133 | MAP3K9 | 0.21840638 |
| 134 | CDK9 | 0.21490816 |
| 135 | CAMK2G | 0.21183158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 6.09144152 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.99276069 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.76887034 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.63674470 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.16708775 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.06799641 |
| 7 | Parkinsons disease_Homo sapiens_hsa05012 | 2.90152608 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.87365175 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.61674184 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.61571652 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.55528153 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.45953391 |
| 13 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.37270533 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 2.35208375 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.22112704 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92107678 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.91927141 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.85122881 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.75170262 |
| 20 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.74368682 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.73558548 |
| 22 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.65856799 |
| 23 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.58938783 |
| 24 | Purine metabolism_Homo sapiens_hsa00230 | 1.41423184 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.40265072 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33922364 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26292762 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.26184072 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25459573 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.21771109 |
| 31 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.13816781 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07011492 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.06293452 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.05835162 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93450186 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88257402 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87359954 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84959600 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.81686254 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81069234 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80938609 |
| 42 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78394320 |
| 43 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75536818 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75239752 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73849314 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72062048 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69367245 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66920489 |
| 49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65980627 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.65968906 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.65940903 |
| 52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.65791307 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65507863 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64539252 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64211838 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63255622 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.61412423 |
| 58 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60053757 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59817852 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.59710817 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57520009 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57457591 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57073907 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 0.56188281 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55567158 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55121673 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53025168 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51361330 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50414589 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.48380920 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47987021 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47548760 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45869087 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45154980 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.44486483 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44200841 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.44090189 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.43815625 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43411818 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43048403 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40994147 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39990370 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.38715206 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37396171 |
| 85 | Legionellosis_Homo sapiens_hsa05134 | 0.36615081 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36441475 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35749456 |
| 88 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35096167 |
| 89 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34622793 |
| 90 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34614356 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.33297797 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33066207 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32324773 |
| 94 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31923712 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31321442 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.30689625 |
| 97 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.29474714 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28271441 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28037113 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27401826 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27363705 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27083614 |
| 103 | Leishmaniasis_Homo sapiens_hsa05140 | 0.26605480 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.26466689 |
| 105 | Shigellosis_Homo sapiens_hsa05131 | 0.25738243 |
| 106 | Phototransduction_Homo sapiens_hsa04744 | 0.25432413 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.24764544 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.24179772 |
| 109 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.23969440 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.23775096 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.23587530 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21215356 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.21130089 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.20678345 |
| 115 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20478868 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20264388 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19719786 |
| 118 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18722985 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.18709992 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18504296 |
| 121 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.18049217 |
| 122 | Apoptosis_Homo sapiens_hsa04210 | 0.16768951 |
| 123 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.16136916 |
| 124 | Hepatitis B_Homo sapiens_hsa05161 | 0.14565419 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.12914010 |
| 126 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.12712537 |
| 127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12330712 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12005129 |
| 129 | Influenza A_Homo sapiens_hsa05164 | 0.11376335 |
| 130 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.10212986 |
| 131 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.10172430 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.09910252 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.09439448 |
| 134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.09420227 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.09380581 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.08330173 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.08099574 |
| 138 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.07998717 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.07909580 |
| 140 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.07510149 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.06880640 |
| 142 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.05845897 |

